EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comorbidities and health‐care use prior to early‐onset Alzheimer's disease: A population‐based case–control study

Laura Leppänen, Adolfina Lehtonen, Mikko Aaltonen, Kalle Aho, Ave Kivisild, Abbe Ullgren, Iina Rinnankoski, Helmi Soppela, Annakaisa Haapasalo, Anne M Portaankorva, Päivi Hartikainen, Kasper Katisko und 2 weitere

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.10.2026. Verfasst von Laura Leppänen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Clinical Medicine, Neurology, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Finnish Medical Foundation, Finnish Alzheimer's Disease Research Society, Finnish Brain Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We examined whether comorbidities and health‐care use differ between individuals later diagnosed with early‐onset Alzheimer's disease (EOAD) and matched controls during the 15 years preceding diagnosis. METHODS This population‐based case–control study included 407 EOAD patients diagnosed at two Finnish university hospitals (2010–2021), and 4035 age‐ and sex‐matched controls. Prior diagnoses and health‐care visits were obtained from nationwide registers. RESULTS EOAD patients had higher prevalence of vertigo (5.9% vs. 2.1%, p < 0.001), depression (5.7% vs. 2.3%, p < 0.001), headache (4.9% vs. 1.6%, p < 0.001), delirium (1.5% vs. 0.1%, p < 0.001), brain injuries (2.9% vs. 0.9%, p = 0.002), thyroid disorders (2.5% vs. 0.8%, p = 0.008), alcohol‐related disorders (3.4% vs. 1.4%, p = 0.009), epilepsy (2.2% vs. 0.7%, p = 0.009), strokes (4.4% vs. 2.0%, p = 0.008), and otorhinolaryngologic diseases (5.2% vs. 2.9%, p = 0.027) 1–5 years before diagnosis. Only otorhinolaryngologic diseases (4.7% vs. 2.1%, p = 0.036) differed 6 to 10 years prior, whereas no differences were seen 11 to 15 years before diagnosis. Hypertension and dyslipidemia showed no between‐group differences. Health‐care use increased markedly from year before EOAD diagnosis. DISCUSSION EOAD is preceded by recognizable patterns of morbidity and increased health‐care use, which may support earlier detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansFemaleMaleCase-Control StudiesComorbidityFinlandAgedAge of OnsetAged, 80 and overPrevalenceMiddle Aged

Stichwörter der Autor:innen

Alzheimer's diseasebrain injurycomorbidityearly‐onset dementiaepilepsyhealth‐care visitotorhinolaryngologic diseasethyroid disorder

Autor:innen und Institutionen

  • Research Unit of Clinical Medicine, Neurology, University of Oulu, Oulu, Finland.
  • Law School, University of Eastern Finland, Joensuu, Finland.
  • Institute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
  • Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Clinical Neurosciences, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Johanna Krüger

Förderung

  • The Finnish Medical Foundation
  • Finnish Alzheimer's Disease Research Society
  • Finnish Brain Foundation
  • The Swedish Dementia Foundation
  • The Foundation for Geriatric Diseases at Karolinska Institutet
  • Uulo Arhio Foundation
  • The Research Council of Finland
  • Wihuri Foundation

Zitieren

APA

Leppänen, L., Lehtonen, A., Aaltonen, M., Aho, K., Kivisild, A., Ullgren, A., Rinnankoski, I., Soppela, H., Haapasalo, A., Portaankorva, A. M., Hartikainen, P., Katisko, K., Solje, E., & Krüger, J. (2026). Comorbidities and health‐care use prior to early‐onset Alzheimer's disease: A population‐based case–control study. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71831

Vancouver

Leppänen L, Lehtonen A, Aaltonen M, Aho K, Kivisild A, Ullgren A, et al. Comorbidities and health‐care use prior to early‐onset Alzheimer's disease: A population‐based case–control study. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71831

BibTeX
@article{Leppnen2026,
  author = {Leppänen, Laura and Lehtonen, Adolfina and Aaltonen, Mikko and Aho, Kalle and Kivisild, Ave and Ullgren, Abbe and Rinnankoski, Iina and Soppela, Helmi and Haapasalo, Annakaisa and Portaankorva, Anne M and Hartikainen, Päivi and Katisko, Kasper and Solje, Eino and Krüger, Johanna},
  title = {Comorbidities and health‐care use prior to early‐onset Alzheimer's disease: A population‐based case–control study},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71831}
}
Kostenlos starten →